These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2253226

  • 1. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells.
    Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK, Goldfine ID.
    Cancer Res; 1990 Dec 15; 50(24):7858-62. PubMed ID: 2253226
    [Abstract] [Full Text] [Related]

  • 2. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.
    Horwitz KB, Freidenberg GR.
    Cancer Res; 1985 Jan 15; 45(1):167-73. PubMed ID: 3838085
    [Abstract] [Full Text] [Related]

  • 3. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X, Lazard Z, Zhang P, Hopp TA, Lee AV.
    Oncogene; 2003 Oct 09; 22(44):6937-41. PubMed ID: 14534541
    [Abstract] [Full Text] [Related]

  • 4. Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor.
    Sarup JC, Rao KV, Fox CF.
    Cancer Res; 1988 Sep 15; 48(18):5071-8. PubMed ID: 3044580
    [Abstract] [Full Text] [Related]

  • 5. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.
    Murphy LJ, Sutherland RL, Stead B, Murphy LC, Lazarus L.
    Cancer Res; 1986 Feb 15; 46(2):728-34. PubMed ID: 3000583
    [Abstract] [Full Text] [Related]

  • 6. Insulin receptor expression and function in human breast cancer cell lines.
    Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R, Goldfine ID, Belfiore A.
    Cancer Res; 1992 Jul 15; 52(14):3924-30. PubMed ID: 1617668
    [Abstract] [Full Text] [Related]

  • 7. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
    Koga M, Musgrove EA, Sutherland RL.
    Cancer Res; 1989 Jan 01; 49(1):112-6. PubMed ID: 2642286
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells.
    Wilding G, Lippman ME, Gelmann EP.
    Cancer Res; 1988 Feb 15; 48(4):802-5. PubMed ID: 3257409
    [Abstract] [Full Text] [Related]

  • 12. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
    Elashry-Stowers D, Zava DT, Speers WC, Edwards DP.
    Cancer Res; 1988 Nov 15; 48(22):6462-74. PubMed ID: 3180062
    [Abstract] [Full Text] [Related]

  • 13. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts CT, LeRoith D, Fontana JA.
    J Cell Physiol; 1993 Jun 15; 155(3):556-67. PubMed ID: 7684042
    [Abstract] [Full Text] [Related]

  • 14. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Hyder SM, Murthy L, Stancel GM.
    Cancer Res; 1998 Feb 01; 58(3):392-5. PubMed ID: 9458078
    [Abstract] [Full Text] [Related]

  • 15. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA, Oza BP, Colomer R, Lupu R.
    Int J Oncol; 2005 Jun 01; 26(6):1507-15. PubMed ID: 15870863
    [Abstract] [Full Text] [Related]

  • 16. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
    Karey KP, Sirbasku DA.
    Cancer Res; 1988 Jul 15; 48(14):4083-92. PubMed ID: 3289739
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM, Lebwohl DE, Cullen KJ, Rubin MS, Rosen N, Mendelsohn J, Miller WH.
    J Cell Physiol; 1995 Oct 15; 165(1):212-21. PubMed ID: 7559803
    [Abstract] [Full Text] [Related]

  • 18. Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation.
    Shao ZM, Sheikh MS, Rishi AK, Dawson MI, Li XS, Wilber JF, Feng P, Fontana JA.
    Exp Cell Res; 1995 May 15; 218(1):1-8. PubMed ID: 7737350
    [Abstract] [Full Text] [Related]

  • 19. Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75.
    Carvajal A, Espinoza N, Kato S, Pinto M, Sadarangani A, Monso C, Aranda E, Villalon M, Richer JK, Horwitz KB, Brosens JJ, Owen GI.
    Breast Cancer Res Treat; 2005 Nov 15; 94(2):171-83. PubMed ID: 16175315
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H, Pelzer AM, Kiang DT, Yee D.
    Cancer Res; 2007 Jan 01; 67(1):391-7. PubMed ID: 17210722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.